Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-005814·ASTRAZENECA PLC
Schedule 13D ownership disclosure
CELLECTIS S A
Ordinary shares, nominal value of EUR0.05 per ordinary share · CUSIP: 15117K103
Event date: 2025-01-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AstraZeneca PLCReported CIK 0000901832
Shares: 44,000,000.00 · Class: 44.0%
- AstraZeneca Holdings B.V.
Shares: 44,000,000.00 · Class: 44.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-005814
- Form type
- SCHEDULE 13D/A
- Filer
- ASTRAZENECA PLC
- CIK
- CIK 901832
- Filed
- Jan 24, 2025
- Reporting period
- Jan 23, 2025
- Description
- Schedule 13D beneficial ownership